In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis for a Program III drug. This rescheduling will figure out that cannabis has legitimate medical applications and will help open up the doorway to analysis on other prospective procedure employs. One particular prospective exception for these https://thcdisposables.co.uk/